Table 4.
Reproducibility of endothelial function assessments in patients with cystic fibrosis
Between-Day Pre Visit 1 vs. Pre Visit 2 |
||||||||
---|---|---|---|---|---|---|---|---|
Variable | Pre Visit 1 | Pre Visit 2 | t-test | CV | CV′ | ICC | r | BA plot |
Diameter, mm | ||||||||
Baseline | 3.07 (0.53) | 3.04 (0.64) | 0.558* | 19.9* | 0.01* | 0.997, P < 0.01* | 0.979, P < 0.01* | X* |
Peak | 3.32 (0.61) | 3.21 (0.63) | 0.576* | 18.7* | 0.02* | 0.985, P < 0.01* | 0.970, P < 0.01* | X* |
FMD, % | 7.6 (4.1) | 7.5 (4.3) | 0.615* | 52.0 | 2.07* | 0.940, P < 0.01* | 0.982, P < 0.01* | X* |
FMD (%)/shear (s-1, AUC) | 0.16 (0.06) | 0.15 (0.07) | 0.507* | 39.2 | 0.05* | 0.854, P < 0.01* | 0.825, P < 0.01* | X* |
Values are means (SD). Reproducibility was evaluated using t-test statistic (P value), coefficient of variation (CV = SD/mean × 100), CV′ [CV′ = (100 × SD)/(mean + 100)], intraclass correlation coefficient (ICC), Pearson’s correlation coefficient (r), and Bland-Altman (BA) plot. X in the BA cell indicates an acceptable plot. FMD, flow mediated dilation.
Acceptable reproducibility.